210 related articles for article (PubMed ID: 8232088)
1. [How many patients with chronic viral hepatitis qualify for interferon therapy? Prospective analysis of university ambulatory care].
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Med Klin (Munich); 1993 Sep; 88(9):511-5, 562. PubMed ID: 8232088
[TBL] [Abstract][Full Text] [Related]
2. [Waiting time for and length of physicianc's consultation define the patient-physician interaction: results of a prospective study in 478 patients with chronic viral hepatitis].
Niederau C; Bemba G; Kautz A; Bertram T; Schweizer R; van Thiel I
Z Gastroenterol; 2010 Apr; 48(4):455-64. PubMed ID: 20352592
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiology of HBV infections and possibilities for therapeutic actions in children and adolescents with end-stage renal failure treated with dialysis].
Zwolińska D; Inglot M; Makulska I; Gładysz A; Szprynger K; Szczepańska M; Pietrzyk J; Zachwieja K; Zurowska A; Zachwieja J; Rajkowski T; Jobs K; Latoszyńska J; Jander A
Pol Merkur Lekarski; 2001 Apr; 10(58):267-70. PubMed ID: 11434173
[TBL] [Abstract][Full Text] [Related]
4. Coinfections with hepatitis g and/or c virus in hepatitis B-related chronic liver disease.
Pramoolsinsap C; Sirikulchayanonta V; Busakorn W; Poovorawan Y; Hirsch P; Theamboonlers A; Lerdverasirikul P
Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):741-9. PubMed ID: 10928369
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications.
Olaso V; Córdoba J; Berenguer M; Prieto M; Lainez B; Argüello L; Valverde J; Pascual S; Gobernado M; Berenguer J
Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839
[TBL] [Abstract][Full Text] [Related]
6. [Seroprevalence of hepatitis B and C viruses in a psychiatric institution].
Eveillard M; Daroukh A; Desjardins P; Legrand S; Odzo-Gakala M; Bourlioux P
Pathol Biol (Paris); 1999 May; 47(5):543-8. PubMed ID: 10418037
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
Zielińska W; Korczak-Rogoń A; Paszkiewicz J; Kowalik M; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):359-66. PubMed ID: 9017152
[TBL] [Abstract][Full Text] [Related]
8. [Re-treatment with interferon-alpha in chronic hepatitis B and C virus infection].
Teuber G; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
Z Gastroenterol; 1995 Feb; 33(2):94-8. PubMed ID: 7725763
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
10. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group.
Kaur S; Rybicki L; Bacon BR; Gollan JL; Rustgi VK; Carey WD
Hepatology; 1996 Nov; 24(5):979-86. PubMed ID: 8903363
[TBL] [Abstract][Full Text] [Related]
11. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients.
Fagiuoli S; Pevere S; Minniti F; Livi U; Caforio AL; Naccarato R; Chiaramonte M
Transplantation; 2003 Apr; 75(7):982-6. PubMed ID: 12698084
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of viral activity in dual infection with hepatitis B and C in chronic liver disease.
Guptan RC; Thakur V; Malhotra V; Sarin SK
J Assoc Physicians India; 2002 May; 50(5):651-5. PubMed ID: 12186118
[TBL] [Abstract][Full Text] [Related]
13. [Socio-economical aspects, quality of life and state of knowledge in hepatitis B patients. Socio-economical aspects in hepatitis B].
Niederau C; Fischer C; Kautz A
Z Gastroenterol; 2007 May; 45(5):355-68. PubMed ID: 17503314
[TBL] [Abstract][Full Text] [Related]
14. Long-term results with interferon therapy in chronic type B hepatitis: a prospective randomized trial.
Mazzella G; Saracco G; Festi D; Rosina F; Marchetto S; Jaboli F; Sostegni R; Pezzoli A; Azzaroli F; Cancellieri C; Montagnani M; Roda E; Rizzetto M
Am J Gastroenterol; 1999 Aug; 94(8):2246-50. PubMed ID: 10445557
[TBL] [Abstract][Full Text] [Related]
15. [Chronic hepatitis: the etiological spectrum. The implications for treatment].
Velosa J; Ramalho F; Serejo F; Marinho R; de Moura MC
Acta Med Port; 1993 Jun; 6(6):233-8. PubMed ID: 8368089
[TBL] [Abstract][Full Text] [Related]
16. Treatment of six patients with chronic active HCV hepatitis, with low dose natural human interferon alpha administered orally.
Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA
Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):253-7. PubMed ID: 8129569
[TBL] [Abstract][Full Text] [Related]
17. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
18. A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin.
Yalcin K; Degertekin H; Yildiz F; Kilinc N
J Gastroenterol; 2003; 38(8):796-800. PubMed ID: 14505137
[TBL] [Abstract][Full Text] [Related]
19. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
[TBL] [Abstract][Full Text] [Related]
20. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
